MxDx Bio Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
MxDx Bio General Information
Description
Developer of biomimetic extracellular matrix technologies designed for biomedical research and precision medicine. The company's platform provides tissue-derived scaffolds and hydrogels for three-dimensional bioprinting, disease modeling, and drug screening, enabling researchers and clinicians to study human tissue environments and advance diagnostics and personalized medicine.
Contact Information
Website
www.mxdxbio.comCorporate Office
- 120 North Pine Street
- Suite 209
- Spokane, WA 99202
- United States
Corporate Office
- 120 North Pine Street
- Suite 209
- Spokane, WA 99202
- United States
MxDx Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 28-Oct-2026 | Completed | Out of Business | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. University Spin-Out | 23-Jul-2020 | Completed | Generating Revenue |
MxDx Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MxDx Bio FAQs
-
When was MxDx Bio founded?
MxDx Bio was founded in 2020.
-
Where is MxDx Bio headquartered?
MxDx Bio is headquartered in Spokane, WA.
-
What industry is MxDx Bio in?
MxDx Bio’s primary industry is Drug Discovery.
-
Is MxDx Bio a private or public company?
MxDx Bio is a Private company.
-
What is MxDx Bio’s current revenue?
The current revenue for MxDx Bio is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
